Troubled Japanese firm Nichi-Iko Pharmaceutical has named Sandoz Japan country head Shingo Iwamoto as its choice to become the firm’s next president and CEO, after announcing late last year that chief executive Yuichi Tamura was to resign. (Also see "Nichi-Iko Set To Delist In March As Tamura Steps Down As CEO" - Generics Bulletin, 6 December, 2022.)
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?